Use

The α-Fetoprotein (AFP) With AFP-L3% (Serial Monitor) test is primarily used for long-term serial monitoring of patients. It provides a color graphic summary report to help physicians track changes in AFP levels in the serum over time. Serial monitoring can aid in the assessment and monitoring of conditions such as hepatic cancer and teratomas. However, it is important to note that values obtained with different assay methods should not be used interchangeably, and results should not be interpreted as absolute evidence of the presence or absence of malignant disease.